Your search found the following article in our index:

Ethinylestradiol and drospirenone (Yasmine®)

UK Medicines Information, 2003

· It has similar contraceptive efficacy and cycle control to other combined oral contraceptives.
to initial claims by the manufacturer, there is no compelling evidence that its effects on skin, premenstrual symptoms, and feelings of well being are any different to standard combined oral contraceptives.
One tablet daily for 21 days; subsequent courses repeated after 7-day tablet free interval (during which withdrawal bleeding occurs)
investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhoea.
Table 1 ­ Comparative studies of two oral contraceptives containing either drospirenone or desogestrel.
(If out of 100 women using a contraceptive over a period of one year, one woman becomes pregnant the Pearl index is 1.0.)

View rest of article at www.ukmi.nhs.uk «

Related articles

Below are some of our articles related to the article above:

The TRIP Database is a clinical search tool designed to allow health professionals to rapidly identify the highest quality clinical evidence for clinical practice.

Registered users (registration is free) benefit from extra features such as CPD, search history, and collaborative tools. Register here, or Login if you have registered before.

Find out more about Trip Database.